Effect of salmeterol on Haemophilus influenzae infection of respiratory mucosa in vitro

European Respiratory Journal

Volumn 11, Issue 1, 1998, Pages 86-90

  Dowling, R B ^a   Johnson, M ^b   Cole, P J ^a   Wilson, R ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Electron microscopy; Epithelium; Haemophilus influenzae; Organ culture; Salmeterol

Indexed keywords

SALMETEROL;

ADENOID; ARTICLE; BACTERIUM ADHERENCE; CELL PROTECTION; CILIATED EPITHELIUM; CONTROLLED STUDY; DISEASE SEVERITY; HAEMOPHILUS INFLUENZAE; HUMAN TISSUE; NONHUMAN; ORGAN CULTURE; POPULATION DENSITY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT MUCOSA; SCANNING ELECTRON MICROSCOPY; TISSUE INJURY;

ADENOIDS; ADRENERGIC BETA-AGONISTS; ALBUTEROL; BACTERIAL ADHESION; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; MICROSCOPY, ELECTRON, SCANNING; MUCOUS MEMBRANE; ORGAN CULTURE TECHNIQUES; RESPIRATORY SYSTEM;

EID: 0031915354     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.11010086     Document Type: Article

References (26)

1. Murphy TF, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992; 146: 1067-1083.
2. Turk DC. The pathogenicity of Haemophilus influenzae. J Med Microbiol 1984; 18: 1-16.
3. May JR, Herrick NC, Thompson D. Bacterial infection in cystic fibrosis. Arch Dis Child 1972; 47: 908-913.
4. Cole P. Bronchiectasis. In: Brewis RAL, Corin B, Geddes DM, Gibson GT, eds. Respiratory Medicine. 2nd edition. Volume 2. London, WB Saunders Company Ltd., 1995; pp. 1286-1316.
5. Farley MM, Stephens DS, Mulks MH, et al. Pathogenesis of IgA 1 protease producing and non-producing Haemophilus influenzae in human nasopharyngeal organ culture. J Infect Dis 1986; 154: 752-759.
6. Read RC, Wilson R, Rutman A, et al. Interaction of non-typable Haemophilus influenzae with human respiratory mucosa in vitro. J Infect Dis 1991; 163: 549-558.
7. Khair OA, Devalia JL, Abdelaziz MM, Sapsford RJ, Taraf H, Davies RJ. Effect of Haemophilus influenzae endotoxin on the synthesis of IL-6, IL-8, TNFα and expression of ICAM-1 in cultured human bronchial epithelial cells. Eur Respir J 1994; 7: 2109-2116.
8. Adler KB, Hendley DD, Davies GS. Bacteria associated with obstructive pulmonary disease elaborate extracellular products that stimulate mucin secretion by explants of guinea pig airways. Am J Pathol 1986; 125: 501-514.
9. Wilson R, Read R, Cole P. Interaction of Haemophilus influenzae with mucus, cilia and respiratory epithelium. J Infect Dis 1992: 165: S100-S102.
10. Wilson R, Moxon ER. Molecular basis of Haemophilus influenzae pathogenicity in the respiratory tract. In: Griffiths E, Donchie W, Stephen J, eds. Bacterial Infections of Respiratory and Gastrointestinal Mucosa. Society for General Microbiology. London, IRL Press, 1988; pp. 29-40.
11. Cole MF, Hale CA. Cleavage of chimpanzee secretory immunoglobulin A by Haemophilus influenzae IgA1 protease. Microb Pathogen 1991; 11: 39-46.
12. Wilson R, Dowling RB, Jackson AD. The biology of bacterial colonization and invasion of the respiratory mucosa. Eur Respir J 1996; 9: 1523-1530.
13. Devalia JL, Sapeford RJ, Rusznak C, Toumbis MJ, Davies RJ. The effects of salmeterol and salbutamol on ciliary beat frequency of cultured human bronchial epithelial cells, in vitro. Pulmon Pharmacol 1992; 5: 257-263.
14. 2-agonist. Br Med J 1990; 301: 1365-1368.
15. 2-adrenoceptor agonist, salmeterol. Br J Pharmacol 1993; 108: 507-515.
16. Dowling RB, Rayner CFJ, Rutman A, et al. Effect of salmeterol on Pseudomonas aeruginosa infection of respiratory mucosa. Am J Respir Crit Care Med 1997; 155: 327-336.
17. Kanthakumar K, Cundell DR, Johnson M, et al. Effect of salmeterol on human nasal epithelial cell ciliary beating: inhibition of the ciliotoxin, pyocyanin. Br J Pharmacol 1994; 112: 493-498.
18. Kanthakumar K, Taylor G, Tsang KWT, et al. Mechanisms of action of Pseudomonas aeruginosa pyocyanin on human ciliary beat in vitro. Infect Immun 1993; 61: 2848-2853.
19. Tsang KWT, Rutman A, Tanaka E, et al. Interaction of Pseudomonas aeruginosa with human respiratory mucosa in vitro. Eur Respir J 1994; 7: 1746-1753.
20. Jackson AD, Rayner CFJ, Dewar A, Cole PJ, Wilson R. A human respiratory-tissue organ culture incorporating an air-interface. Am J Respir Crit Care Med 1996; 153: 1130-1135.
21. Jackson AD, Cole PJ, Wilson R. Comparison of Haemophilus influenzae type B interaction with respiratory mucosa organ cultures maintained with an air-mucosal interface or immersed in medium. Infect Immun 1996; 64: 2353-2355.
22. Rhodes DG, Newton R, Butler R, Herbette L. Equilibrium and kinetic studies of the interactions of salmeterol with membrane bilayers. Mol Pharmacol 1992; 42: 596-602.
23. Anderson GP, Linden A, Rabe KF. Why are long-acting beta-adrenoceptor agonists long acting? Eur Respir J 1994; 7: 569-578.
24. Johnson M, Butchers PR, Coleman RA, et al. The pharmacology of salmeterol. Life Sciences 1993; 52: 2131-2143.
25. Green SA, Spasoff AP, Coleman RA, Johnson M, Liggett SB. Sustained activation of a G protein-coupled receptor via "anchored" agonist binding. Molecular localization of the salmeterol exosite within the beta 2-adrenergic receptor. J Biol Chem 1996; 271: 24029-24035.
26. Janson C, Boe J, Boman G, Mossberg B, Svedmyr N. Bronchodilator intake and plasma levels on administration for severe acute asthma. Eur Respir J 1992; 5: 80-85.